Type 1 Diabetes: Clinical Trials

1,207 trials for Type 1 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

753 completed, 129 unknown, 125 recruiting, 57 terminated. 585 Not applicable, 163 Phase 2, 109 Phase 1, 77 Phase 3, 53 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable585Completed 369, Unknown 58, Recruiting 56, Withdrawn 28, Terminated 27, Active not recruiting 24, Not yet recruiting 15, Enrolling by invitation 5, Suspended 3
Phase 2163Completed 104, Recruiting 20, Unknown 12, Active not recruiting 8, Terminated 8, Withdrawn 6, Not yet recruiting 5
Phase 1109Completed 75, Terminated 11, Recruiting 9, Unknown 6, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2, Suspended 1
Phase 377Completed 48, Recruiting 8, Unknown 8, Terminated 4, Withdrawn 4, Active not recruiting 3, Not yet recruiting 2
Phase 453Completed 40, Unknown 5, Terminated 3, Recruiting 2, Withdrawn 2, Not yet recruiting 1
Early Phase 125Completed 14, Recruiting 4, Active not recruiting 2, Unknown 2, Withdrawn 2, Terminated 1

Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Galactose as a Substrate for Post-Exercise Skeletal Muscle Glycogen Repletion in Individuals With Type 1 Diabetes
galactose - Type 1 Diabetes
Not applicableNot yet recruitingUniversity of Aarhus162027-02-012026-08-19
ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
ENCRT-103-hPI encompasses the ENC-103 device, which will be implanted once loaded with primary islet cargo. - Type 1 Diabetes
Phase 1Not yet recruitingEncellin102027-01-062026-08-20
Inspiratory Muscle Strength Training in Adults With Type 1 Diabetes
High-Resistance Inspiratory Muscle Strength Training, Sham Inspiratory Muscle Strength Training - Type 1 Diabetes
Not applicableNot yet recruitingFlorida State University302027-01-012026-10-08
Verapamil In Preclinical Type 1 Diabetes
Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release, Placebo, blood sampling - Type 1 Diabetes
Phase 2 / Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris502027-01-012026-10-22
Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus
Psychological Interventions for children and adolescents - Type 1 Diabetes
Not applicableNot yet recruitingUniversity of Pittsburgh502026-12-012026-07-07
Precision T1D Platform - New Therapies for Cardio-Renal Complications
Finerenone, Sotagliflozin - Type 1 Diabetes, T1D Heart Failure
Phase 2Not yet recruitingOregon Health and Science University572026-11-012026-08-10
Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
Mindfulness-Based Stress Reduction - Virtual Reality, Stress tip sheet - Type 1 Diabetes
Not applicableNot yet recruitingWayne State University482026-10-312026-10-16
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Semaglutide, Placebo - Type 1 Diabetes, Overweight , Obesity
Phase 2 / Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre402026-10-132026-10-23
Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes
Insulin Self-Management Know-Find-Solve Activity Book, Routine education - Type 1 Diabetes, Children
Not applicableRecruitingMarmara University402026-10-052026-10-08
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Next Generation Extended Wear Sensors - Type 1 Diabetes, Type 2 Diabetes
Not applicableRecruitingMedtronic MiniMed, Inc.15002026-10-052026-10-20
C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
C-Carbs Program - Type 1 Diabetes
Not applicableRecruitingUniversity of California, Los Angeles402026-09-302026-09-08
Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Intensive lifestyle modification (hypocaloric Mediterranean diet and promotion of physical activity), Butyrate, Intensive lifestyle modification + butyrate - Type 1 Diabetes
Not applicableNot yet recruitingFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2002026-09-152026-07-06
Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes
Automated Insulin Delivery (AID) - Type 1 Diabetes, Pregnancy
Not applicableNot yet recruitingMayo Clinic322026-09-012026-09-08
Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes
Type 1 Diabetes, Autoimmunity
Not yet recruitingIRCCS San Raffaele842026-09-012026-07-14
Evaluating the Occurrence of DKA in People With Type I Diabetes
Abbott Continuous Dual Glucose Ketone Monitoring System - Type 1 Diabetes
Not yet recruitingAbbott Diabetes Care12002026-09-012026-07-31
Screening For Social Determinants Of Health In Routine Diabetes Care
Social Determinants of Health (SDOH) Screening and Referral - Type 1 Diabetes
Not applicableNot yet recruitingUniversity of California, Los Angeles1502026-09-012026-07-16
Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes
MASLD, Type 1 Diabetes
Not yet recruitingSohag University2502026-08-222026-08-06
The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment
Omnipod 5, Multiple daily injections of insulin - Type 1 Diabetes
Not applicableRecruitingHelsinki University Central Hospital1002026-08-152026-10-14
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Cherry Sports Drink - Non-Nutritive Sweetener, Type 1 Diabetes
Not applicableRecruitingMedical College of Wisconsin202026-08-052026-10-20
Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)
Dexcom G7, ViewsEMR telemetry - Type 1 Diabetes, Type 2 Diabetes Treated With Insulin
Not yet recruitingImperial College Healthcare NHS Trust702026-08-012026-08-17

Showing 20 of 1207. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 1 (1207)  ·  Diabetes Mellitus (140)  ·  Hypoglycemia (117)  ·  Insulin Resistance (77)  ·  Diabetes Mellitus, Type 2 (76)  ·  Motor Activity (49)  ·  Hyperglycemia (29)  ·  Obesity (16)  ·  Autoimmune Diseases (14)  ·  Diabetic Nephropathies (11)  ·  Overweight (11)  ·  Cardiovascular Diseases (10)  ·  Feeding and Eating Disorders (10)  ·  Depression (7)  ·  Diabetes Complications (7)

Broader conditions

Nutritional and Metabolic Diseases (1207)  ·  Glucose Metabolism Disorders (1205)  ·  Immune System Diseases (1205)  ·  Endocrine System Diseases (1204)  ·  Metabolic Diseases (1203)  ·  Autoimmune Diseases (1193)  ·  Diabetes Mellitus (1067)  ·  Hyperinsulinism (79)  ·  Behavior (76)  ·  Pathological Conditions, Signs and Symptoms (69)  ·  Signs and Symptoms (51)  ·  Female Urogenital Diseases and Pregnancy Complications (28)  ·  Urogenital Diseases (28)  ·  Nutrition Disorders (23)  ·  Body Weight (22)

Interventions

Insulin (36)  ·  Insulin Aspart (30)  ·  Continuous Glucose Monitoring (28)  ·  Insulin Lispro (24)  ·  Insulin Glargine (20)  ·  Liraglutide (19)  ·  Exercise (17)  ·  Glucagon (15)  ·  Insulin Infusion Systems (14)  ·  Blood Specimen Collection (13)  ·  Sodium Chloride (13)  ·  pramlintide (13)  ·  Pancreas, Artificial (9)  ·  Sitagliptin Phosphate (9)  ·  Drug Delivery Systems (8)

Sponsors

Medtronic MiniMed, Inc. (32)  ·  Institut de Recherches Cliniques de Montreal (31)  ·  Rabin Medical Center (30)  ·  University of Colorado, Denver (30)  ·  Yale University (24)  ·  Steno Diabetes Center Copenhagen (22)  ·  University of Cambridge (17)  ·  Jaeb Center for Health Research (16)  ·  Massachusetts General Hospital (15)  ·  University of Virginia (15)  ·  Assistance Publique - Hôpitaux de Paris (14)  ·  University of Alberta (13)  ·  Joslin Diabetes Center (12)  ·  Medical University of Graz (12)  ·  Oregon Health and Science University (12)

Countries

United States (499)  ·  Canada (110)  ·  France (91)  ·  United Kingdom (76)  ·  Denmark (68)  ·  Israel (51)  ·  Italy (40)  ·  Germany (39)  ·  Spain (39)  ·  China (26)  ·  Austria (23)  ·  Sweden (23)  ·  Belgium (19)  ·  Netherlands (18)  ·  Switzerland (17)

Top investigators

Moshe Phillip, Prof (9)  ·  Roman Hovorka, PhD (9)  ·  Bruce Buckingham, MD (8)  ·  Jordan Pinsker, MD (8)  ·  Stephen N. Davis, MD (7)  ·  Jessica Castle, MD (6)  ·  John Lum, MS (6)  ·  Remi Rabasa-Lhoret (6)  ·  Roy W Beck, MD, PhD (6)  ·  Sue Brown, MD (6)  ·  Bruce A Buckingham, MD (5)

Results publications

PMID 31177185, PMID 35797241, PMID 15793249, PMID 18823656, PMID 19451554, PMID 21225239, PMID 21309844, PMID 21493665, PMID 22996144, PMID 23438305, PMID 23562090, PMID 24170749, PMID 24432999, PMID 24931572, PMID 25078901, PMID 25393157, PMID 26241693, PMID 26844283, PMID 28134564, PMID 28941330, PMID 29873107, PMID 30130323, PMID 30478937, PMID 30585770, PMID 30787930, PMID 30924570, PMID 31615852, PMID 34091488, PMID 3517648, PMID 36482870, PMID 38315506, PMID 38682786, PMID 38773658, PMID 42459945, PMID 8366922, PMID 10024506, PMID 10371488, PMID 10433086, PMID 10605821, PMID 10752702, PMID 10852253, PMID 11208527, PMID 11246868, PMID 11564949, PMID 11679447, PMID 11815483, PMID 12020338, PMID 12176626, PMID 12176628, PMID 12972423

NIH funding

2014 (5), 2018 (4), R01DK069803 (4), R01DK085591 (4), 2019 (3), 2025 (3), K12DK094714 (3), 1DP3DK097705-01 (2), 2015 (2), K23DK119470 (2), P30DK116074 (2), R01DK059067 (2), R01DK077166 (2), R01DK122583 (2), R01DK129553 (2)